Ginkgo Bioworks Hldgs Inc (DNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2006 | 12-2005 | 12-2004 | 12-2003 | 12-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,113,000 | 1,279,000 | 785,000 | 562,527 | 63,787 |
| Depreciation Amortization | 407,000 | 370,000 | 353,000 | 295,449 | 274,955 |
| Income taxes - deferred | -112,000 | -110,000 | -74,000 | -149,001 | -196,644 |
| Accounts receivable | -628,000 | -128,000 | -363,000 | -146,892 | -110,237 |
| Other Working Capital | -385,000 | 130,000 | -237,000 | 169,774 | -132,329 |
| Other Operating Activity | 743,000 | 822,000 | 731,000 | 510,264 | 688,168 |
| Operating Cash Flow | $2,138,000 | $2,363,000 | $1,195,000 | $1,242,121 | $587,700 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,214,000 | -1,400,000 | -650,000 | -321,955 | -322,832 |
| Purchase Of Investment | -1,036,000 | -1,000,000 | -890,000 | -1,760,220 | -812,734 |
| Sale Of Investment | 613,000 | 722,000 | 1,149,000 | 739,867 | 1,746,198 |
| Purchase Sale Intangibles | 9,000 | -45,000 | -64,000 | N/A | N/A |
| Other Investing Activity | -44,000 | -98,000 | -59,000 | -61,307 | -617,125 |
| Investing Cash Flow | $-1,681,000 | $-1,776,000 | $-450,000 | $-1,403,615 | $-6,493 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 1,988,000 | N/A | N/A | N/A |
| Debt Repayment | N/A | -425,000 | N/A | N/A | N/A |
| Common Stock Issued | 385,000 | 821,000 | 505,000 | 526,861 | 74,164 |
| Common Stock Repurchased | -996,000 | -2,016,000 | -1,352,000 | -201,345 | -692,752 |
| Other Financing Activity | 179,000 | 0 | 0 | 0 | -149,692 |
| Financing Cash Flow | $-432,000 | $368,000 | $-847,000 | $325,516 | $-768,280 |
| Beginning Cash Position | 1,225,000 | 270,000 | 372,000 | 208,130 | 395,203 |
| End Cash Position | 1,250,000 | 1,225,000 | 270,000 | 372,152 | 208,130 |
| Net Cash Flow | $25,000 | $955,000 | $-102,000 | $164,022 | $-187,073 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,138,000 | 2,363,000 | 1,195,000 | 1,242,121 | 587,700 |
| Capital Expenditure | -1,214,000 | -1,400,000 | -650,000 | -321,955 | -322,832 |
| Free Cash Flow | 924,000 | 963,000 | 545,000 | 920,166 | 264,868 |